Suvretta Capital Management, LLC

Investment Portfolio & 13F Holdings Analysis

About
CIK: 0001569064
Type: FundHoldings: 100Value: $2.7BLatest: 2025Q1

SUVRETTA CAPITAL MANAGEMENT, LLC is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 100 holdings worth $2.7 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
100
Total Value
2694889925
Accession Number
0001172661-25-002306
Form Type
13F-HR
Manager Name
Suvretta-Capital-Management
Data Enrichment
97% identified
97 identified3 unidentified

Holdings

100 positions • $2.7B total value
Manager:
Search and click to pin securities to the top
Page 1 of 5
SPDR S&P 500 ETF TRUST
Shares:400.0K
Value:$223.8M
% of Portfolio:8.3% ($223.8M/$2.7B)
Arcutis Biotherapeutics, Inc.
Shares:11.4M
Value:$178.7M
% of Portfolio:6.6% ($178.7M/$2.7B)
Biohaven Ltd.
Shares:5.6M
Value:$135.1M
% of Portfolio:5.0% ($135.1M/$2.7B)
Benitec Biopharma Inc.
Shares:9.9M
Value:$128.5M
% of Portfolio:4.8% ($128.5M/$2.7B)
Legend Biotech Corp
Shares:3.7M
Value:$127.2M
% of Portfolio:4.7% ($127.2M/$2.7B)
INSMED Inc
Shares:1.5M
Value:$113.9M
% of Portfolio:4.2% ($113.9M/$2.7B)
89bio, Inc.
Shares:14.3M
Value:$104.2M
% of Portfolio:3.9% ($104.2M/$2.7B)
Meta Platforms, Inc.
Shares:179.7K
Value:$103.6M
% of Portfolio:3.8% ($103.6M/$2.7B)
46116X101
Shares:700.9K
Value:$92.5M
% of Portfolio:3.4% ($92.5M/$2.7B)
Ultragenyx Pharmaceutical Inc.
Shares:2.0M
Value:$73.3M
% of Portfolio:2.7% ($73.3M/$2.7B)
MICROSOFT CORP
Shares:180.1K
Value:$67.6M
% of Portfolio:2.5% ($67.6M/$2.7B)
AMAZON COM INC
Shares:354.4K
Value:$67.4M
% of Portfolio:2.5% ($67.4M/$2.7B)
TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD
Shares:350.5K
Value:$58.2M
% of Portfolio:2.2% ($58.2M/$2.7B)
KalVista Pharmaceuticals, Inc.
Shares:4.9M
Value:$56.7M
% of Portfolio:2.1% ($56.7M/$2.7B)
Apollo Global Management, Inc.
Shares:396.5K
Value:$54.3M
% of Portfolio:2.0% ($54.3M/$2.7B)
Kura Oncology, Inc.
Shares:7.4M
Value:$49.1M
% of Portfolio:1.8% ($49.1M/$2.7B)
CAPITAL ONE FINANCIAL CORP
Shares:245.2K
Value:$44.0M
% of Portfolio:1.6% ($44.0M/$2.7B)
ArriVent BioPharma, Inc.
Shares:2.3M
Value:$43.2M
% of Portfolio:1.6% ($43.2M/$2.7B)
ADVANCED MICRO DEVICES INC
Shares:404.0K
Value:$41.5M
% of Portfolio:1.5% ($41.5M/$2.7B)
Immatics N.V.
Shares:9.1M
Value:$41.2M
% of Portfolio:1.5% ($41.2M/$2.7B)